Kura Oncology Inc is a clinical-stage biopharmaceutical company, that engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small-molecule product candidates that target cell signalling pathways to drive the progressi... Kura Oncology Inc is a clinical-stage biopharmaceutical company, that engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small-molecule product candidates that target cell signalling pathways to drive the progression of various cancers. The company has a lead product candidate, Tipifarnib, which is a farnesyl transferase inhibitor, in both solid tumors and blood cancers. It is advancing KO-947, a small molecule inhibitor of extracellular-signal-regulated kinase (ERK), as a treatment for patients with pancreatic cancer, colorectal cancer, non-small cell lung cancer (NSCLC) and melanoma. Geographically operation of the group is carried through the United States. Show more
SAN DIEGO, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the...
SAN DIEGO, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the...
– Topline data from registration-directed trial of ziftomenib in R/R NPM1-mutant AML expected in early 2025 – – Breakthrough Therapy Designation granted for ziftomenib in R/R NPM1-mutant AML – –...
– Preclinical data suggest combination of ziftomenib and imatinib has potential to resensitize patients to imatinib and induce durable responses – – Proof-of-concept study evaluating ziftomenib...
SAN DIEGO, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.91 | 4.51165096678 | 20.17 | 21.4 | 19.9 | 500277 | 20.68470663 | CS |
4 | 1.19 | 5.98290598291 | 19.89 | 21.569 | 19.12 | 428440 | 20.21132011 | CS |
12 | 0.47 | 2.28044638525 | 20.61 | 23.48 | 17.915 | 640069 | 20.26657392 | CS |
26 | -0.17 | -0.8 | 21.25 | 23.48 | 16.79 | 684013 | 20.36644008 | CS |
52 | 11.45 | 118.899273105 | 9.63 | 24.17 | 7.41 | 949796 | 17.1737279 | CS |
156 | 0.44 | 2.13178294574 | 20.64 | 24.17 | 7.41 | 832194 | 15.07842674 | CS |
260 | 4.66 | 28.3800243605 | 16.42 | 43 | 6.34 | 736858 | 17.92034322 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.